Opendata, web and dolomites

LIBERATE

Blood Biomarker Array Technology

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Project "LIBERATE" data sheet

The following table provides information about the project.

Coordinator
ATTOMARKER LIMITED 

Organization address
address: INNOVATION CENTRE UNIVERSITY OF EXETER RENNES DRIVE
city: EXETER
postcode: EX4 4RN
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country United Kingdom [UK]
 Project website http://www.attomarker.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SMEINST-1-2015
 Funding Scheme SME-1
 Starting year 2015
 Duration (year-month-day) from 2015-07-01   to  2015-10-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    ATTOMARKER LIMITED UK (EXETER) coordinator 50˙000.00

Map

 Project objective

Treatment of patients occurs principally in two places: the primary setting with a physician and the secondary setting in hospital. The remote setting of a care home, the patient’s home or remote isolated communities is by comparison under exploited. Projection of real diagnostic power derived from blood biomarker biochemistry into these remote communities is possible using a small volume multi-biomarker array technology that can deliver all of the tests of a clinical biochemistry laboratory in a small-form disposable format performed by the patient. A telemedicine solution brings the data back to the clinician for expert analysis and diagnosis.

Our blood biomarker array technology will provide healthcare for an aging population keeping them in their homes for longer and provide timely personalised interventions for the management of chronic conditions. “Knowing your numbers” means a patient will understand their own acute phase response to infection or inflammation not requiring the comparison against normal ranges for diagnosis. Preliminary studies indicate 6 assays will be important: CRP and White Blood Cells, markers of the acute phase response; D-dimer the a blood clot biomarker; Troponin I/T/C the heart attack biomarker; and C3 and C4 Complement proteins for differential diagnosis of bacterial infection. The project will look at these and other assays to form a General Diagnostic Array for management of healthcare in remote communities, in health disease and during recovery.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "LIBERATE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "LIBERATE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

LEGACy (2019)

CeLac and European consortium for a personalized medicine approach to Gastric Cancer

Read More  

PanCareFollowUp (2019)

PanCareFollowUp: Novel, patient-centred survivorship care to improve care quality, effectiveness, cost-effectiveness and accessibility for survivors and caregivers

Read More  

EXPERT (2019)

EXpanding Platforms for Efficacious mRNA Therapeutics

Read More